Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.29 and traded as low as $0.24. Northwest Biotherapeutics shares last traded at $0.25, with a volume of 3,653,052 shares traded.
Northwest Biotherapeutics Price Performance
The firm’s 50-day moving average price is $0.27 and its 200 day moving average price is $0.29. The firm has a market cap of $333.51 million, a P/E ratio of -3.08 and a beta of -0.51.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Read More
- Five stocks we like better than Northwest Biotherapeutics
- What Are Some of the Best Large-Cap Stocks to Buy?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- The How and Why of Investing in Gold Stocks
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- How to Profit From Growth Investing
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
